{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:55:24Z","timestamp":1785902124782,"version":"3.56.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"DOI":"10.7759\/cureus.74899","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:27:21Z","timestamp":1733052441000},"source":"Crossref","is-referenced-by-count":3,"title":["A Narrative Review of the Role of Blood Biomarkers in the Risk Prediction of Cardiovascular Diseases"],"prefix":"10.7759","author":[{"given":"Lavanya","family":"Garady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Soota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Shouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal Prasad","family":"Chandrachari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"K V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasan","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanketh V","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavyashree","family":"C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrutika","family":"Munnyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahalya","family":"Gopi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azad","family":"Devyani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases\u2014review of the literature and clinical studies","volume":"23","author":"Surma S","year":"2022","unstructured":"Surma S, Banach M. Fibrinogen and atherosclerotic cardiovascular diseases\u2014review of the literature and clinical studies. Int J Mol Sci. 2022, 23:193.","journal-title":"Int J Mol Sci"},{"key":"ref2","article-title":"Novel biomarkers for cardiovascular risk prediction","volume":"14","author":"Wang J","year":"2017","unstructured":"Wang J, Tan GJ, Han LN, et al.. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol JGC. 2017, 14:135-50.","journal-title":"J Geriatr Cardiol JGC"},{"key":"ref3","article-title":"Identifying novel biomarkers for cardiovascular disease risk prediction","volume":"272","author":"Ge Y","year":"2012","unstructured":"Ge Y, Wang TJ. Identifying novel biomarkers for cardiovascular disease risk prediction. J Intern Med. 2012, 272:430-9.","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.087932","article-title":"Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review","volume":"92","author":"Brindle P","year":"2006","unstructured":"Brindle P, Beswick A, Fahey T, et al.. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart. 2006, 92:1752-9. 10.1136\/hrt.2006.087932","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv336","article-title":"The Framingham heart study: past, present and future","volume":"44","author":"Tsao CW","year":"2015","unstructured":"Tsao CW, Vasan RS. The Framingham heart study: past, present and future. Int J Epidemiol. 2015, 44:1763-6. 10.1093\/ije\/dyv336","journal-title":"Int J Epidemiol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1080\/10408363.2018.1525335","article-title":"Novel biomarkers of cardiovascular disease: applications in clinical practice","volume":"56","author":"Lyngbakken MN","year":"2019","unstructured":"Lyngbakken MN, Myhre PL, R\u00f8sj\u00f8 H, et al.. Novel biomarkers of cardiovascular disease: applications in clinical practice. Crit Rev Clin Lab Sci. 2019, 56:33-60.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015949","article-title":"Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis","volume":"31","author":"Cavero-Redondo I","year":"2017","unstructured":"Cavero-Redondo I, Peleteiro B, \u00c1lvarez-Bueno C, et al.. Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis. BMJ Open. 2017, 31:015949. 10.1136\/bmjopen-2017-015949","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2022.2094534","article-title":"Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease","volume":"78","author":"Sprynger M","year":"2023","unstructured":"Sprynger M, Lancellotti P. Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease. Acta Cardio. 2023, 78:635-6. 10.1080\/00015385.2022.2094534","journal-title":"Acta Cardio"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01445-4","article-title":"HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target","volume":"24","author":"Ceriello A","year":"2022","unstructured":"Ceriello A, Lucisano G, Prattichizzo F, et al.. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target. Cardiovasc Diabetol. 2022, 24:13. 10.1186\/s12933-022-01445-4","journal-title":"Cardiovasc Diabetol"},{"key":"ref10","article-title":"Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)","volume":"6","author":"Khaw KT","year":"2001","unstructured":"Khaw KT, Wareham N, Luben R, et al.. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001, 6:15.","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01015-y","article-title":"HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease","volume":"15","author":"Jiao X","year":"2023","unstructured":"Jiao X, Zhang Q, Peng P, Shen Y. HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease. Diabetol Metab Syndr. 2023, 15:50. 10.1186\/s13098-023-01015-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/db23-454-P","article-title":"454-P: risk stratification of cerebrocardiovascular disease (CVD) according to HbA1c, fasting plasma glucose (FPG), and their combinations in people with prediabetes (preDM)","volume":"72","author":"Murai K","year":"2023","unstructured":"Murai K, Fujihara K, Yaguchi Y, et al.. 454-P: risk stratification of cerebrocardiovascular disease (CVD) according to HbA1c, fasting plasma glucose (FPG), and their combinations in people with prediabetes (preDM). Diabetes. 2023, 72:454. 10.2337\/db23-454-P","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2016.01.011","article-title":"Serum TSH levels are associated with cardiovascular risk factors in overweight and obese adolescents","volume":"92","author":"Souza LL de","year":"2016","unstructured":"Souza LL de, Guedes EP, Teixeira PF dos S, Moreira RO, Godoy-Matos AF, Vaisman M. Serum TSH levels are associated with cardiovascular risk factors in overweight and obese adolescents. J Pediatr. 2016, 92:532-8. 10.1016\/j.jped.2016.01.011","journal-title":"J Pediatr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23062","article-title":"Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction","volume":"41","author":"Seo SM","year":"2018","unstructured":"Seo SM, Koh YS, Park HJ, et al.. Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction. Clin Cardiol. 2018, 41:1367-73. 10.1002\/clc.23062","journal-title":"Clin Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01149-9","article-title":"Normal thyroid stimulating hormone is associated with all-cause mortality in patients with acute myocardial infarction after percutaneous coronary intervention","volume":"29","author":"Ni WC","year":"2023","unstructured":"Ni WC, Kong ST, Lin K, et al.. Normal thyroid stimulating hormone is associated with all-cause mortality in patients with acute myocardial infarction after percutaneous coronary intervention. Eur J Med Res. 2023, 29:199. 10.1186\/s40001-023-01149-9","journal-title":"Eur J Med Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01698-z","article-title":"TSH levels within the normal range and risk of cardiovascular and all-cause mortality among individuals with diabetes","volume":"21","author":"Ni WC","year":"2022","unstructured":"Ni WC, Kong ST, Lin K, et al.. TSH levels within the normal range and risk of cardiovascular and all-cause mortality among individuals with diabetes. Cardiovasc Diabetol. 2022, 21:254. 10.1186\/s12933-022-01698-z","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X18666220428121431","article-title":"A role of thyroid hormones in acute myocardial infarction: an update","volume":"19","author":"Rasool R","year":"2023","unstructured":"Rasool R, Unar A, Jafar TH, et al.. A role of thyroid hormones in acute myocardial infarction: an update. Curr Cardiol Rev. 2023, 19:280422204209. 10.2174\/1573403X18666220428121431","journal-title":"Curr Cardiol Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.18869\/acadpub.mlj.10.5.1","article-title":"Role of homocysteine in diseases: a review","volume":"10","author":"Moradi Binabaj M","year":"2016","unstructured":"Moradi Binabaj M, Joshaghani H, Nejabat M. Role of homocysteine in diseases: a review. Med Lab J. 2016, 10:1-14. 10.18869\/acadpub.mlj.10.5.1","journal-title":"Med Lab J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02000-x","article-title":"The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan","volume":"21","author":"Shih CC","year":"2021","unstructured":"Shih CC, Shih YL, Chen JY. The association between homocysteine levels and cardiovascular disease risk among middle-aged and elderly adults in Taiwan. BMC Cardiovasc Disord. 2021, 21:191. 10.1186\/s12872-021-02000-x","journal-title":"BMC Cardiovasc Disord"},{"key":"ref20","article-title":"The role of homocysteine as a predictor for coronary heart disease","volume":"9","author":"L\u00fchmann D","year":"2007","unstructured":"L\u00fchmann D, Schramm S, Raspe H. The role of homocysteine as a predictor for coronary heart disease. GMS Health Technol Assess. 2007, 9:11.","journal-title":"GMS Health Technol Assess"},{"key":"ref21","article-title":"Plasma ceramides in cardiovascular disease risk stratification","volume":"29","author":"Junqueira DLM","year":"2022","unstructured":"Junqueira DLM, Stach A, Caixeta A, et al.. Plasma ceramides in cardiovascular disease risk stratification. Arq Bras Cardiol. 2022, 29:768-77.","journal-title":"Arq Bras Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx205","article-title":"Plasma ceramides and cardiac risk","volume":"7","author":"Nicholls M","year":"2017","unstructured":"Nicholls M. Plasma ceramides and cardiac risk. Eur Heart J. 2017, 7:1359-60. 10.1093\/eurheartj\/ehx205","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.athplu.2021.09.005","article-title":"Assessment of plasma ceramides as predictor for subclinical atherosclerosis","volume":"45","author":"Mishra PP","year":"2021","unstructured":"Mishra PP, Mishra BH, Lyytik\u00e4inen LP, et al.. Assessment of plasma ceramides as predictor for subclinical atherosclerosis. Atheroscler Plus. 2021, 45:25-31. 10.1016\/j.athplu.2021.09.005","journal-title":"Atheroscler Plus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease","volume":"24","author":"Miller M","year":"2011","unstructured":"Miller M, Stone NJ, Ballantyne C, et al.. Triglycerides and cardiovascular disease. Circulation. 2011, 24:2292-333. 10.1161\/CIR.0b013e3182160726","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.183460","article-title":"Triglyceride and cardiovascular risk: a critical appraisal","volume":"20","author":"Singh AK","year":"2016","unstructured":"Singh AK, Singh R. Triglyceride and cardiovascular risk: a critical appraisal. Indian J Endocrinol Metab. 2016, 20:418-28. 10.4103\/2230-8210.183460","journal-title":"Indian J Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0861","article-title":"Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events","volume":"74","author":"Tanabe N","year":"2010","unstructured":"Tanabe N, Iso H, Okada K, et al.. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events. Circ J Off J Jpn Circ Soc. 2010, 74:1346-56. 10.1253\/circj.cj-09-0861","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000145615.33955.83","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region","volume":"26","author":"Patel A","year":"2004","unstructured":"Patel A, Barzi F, Jamrozik K, et al.. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation. 2004, 26:2678-86. 10.1161\/01.CIR.0000145615.33955.83","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0851-z","article-title":"Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies","volume":"15","author":"Ye X","year":"2019","unstructured":"Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019, 15:48. 10.1186\/s12933-019-0851-z","journal-title":"Cardiovasc Diabetol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/hc3501.095214","article-title":"Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions","volume":"104","author":"Sharrett AR","year":"2001","unstructured":"Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions. Circulation. 2001, 104:10. 10.1161\/hc3501.095214","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.3.830","article-title":"LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL","volume":"20","author":"Howard BV","year":"2000","unstructured":"Howard BV, Robbins DC, Sievers ML, et al.. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. Arterioscler Thromb Vasc Biol. 2000, 20:830-5. 10.1161\/01.ATV.20.3.830","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","article-title":"Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios","volume":"43","author":"Kinosian B","year":"1995","unstructured":"Kinosian B, Glick H, Preiss L, Puder KL. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med Off Publ Am Fed Clin Res. 1995, 43:443-50.","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051422","article-title":"Association between very low-density lipoprotein cholesterol (VLDL-C) and carotid intima-media thickness in postmenopausal women without overt cardiovascular disease and on LDL-C target levels","volume":"9","author":"Gentile M","year":"2020","unstructured":"Gentile M, Iannuzzi A, Giallauria F, et al.. Association between very low-density lipoprotein cholesterol (VLDL-C) and carotid intima-media thickness in postmenopausal women without overt cardiovascular disease and on LDL-C target levels. J Clin Med. 2020, 9:1422. 10.3390\/jcm9051422","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.08.030","article-title":"The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease","volume":"322","author":"Heidemann BE","year":"2021","unstructured":"Heidemann BE, Koopal C, Bots ML, et al.. The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease. Int J Cardiol. 2021, 322:251-7. 10.1016\/j.ijcard.2020.08.030","journal-title":"Int J Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000255580.73689.8e","article-title":"Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B","volume":"27","author":"Benn M","year":"2007","unstructured":"Benn M, Nordestgaard BG, Jensen GB, et al.. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B. Arterioscler Thromb Vasc Biol. 2007, 27:661-70. 10.1161\/01.ATV.0000255580.73689.8e","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1373\/jalm.2016.021006","article-title":"Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (LMBP) systematic review","volume":"1","author":"Sandhu PK","year":"2016","unstructured":"Sandhu PK, Musaad SMA, Remaley AT, et al.. Lipoprotein biomarkers and risk of cardiovascular disease: a laboratory medicine best practices (LMBP) systematic review. J Appl Lab Med. 2016, 1:214-29. 10.1373\/jalm.2016.021006","journal-title":"J Appl Lab Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076310","article-title":"The correlation of apolipoprotein b with alterations in specific fat depots content in adults","volume":"24","author":"Chen J","year":"2023","unstructured":"Chen J, Li K, Shao J, Lai Z, Feng Y, Liu B. The correlation of apolipoprotein b with alterations in specific fat depots content in adults. Int J Mol Sci. 2023, 24:6310. 10.3390\/ijms24076310","journal-title":"Int J Mol Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic T","year":"2022","unstructured":"Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD. Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk. J Am Heart Assoc. 2022, 11:e025858. 10.1161\/JAHA.122.025858","journal-title":"J Am Heart Assoc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.05.052","article-title":"Apolipoprotein particle and cardiovascular risk prediction (from a prospective cohort study)","volume":"201","author":"Su X","year":"2023","unstructured":"Su X, Wang M, Zuo Y, et al.. Apolipoprotein particle and cardiovascular risk prediction (from a prospective cohort study). Am J Cardiol. 2023, 201:34-41. 10.1016\/j.amjcard.2023.05.052","journal-title":"Am J Cardiol"},{"key":"ref39","article-title":"Lipoprotein A","author":"Farzam K","year":"2024","unstructured":"Farzam K, Senthilkumaran S, Zubair M. Lipoprotein A. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad055","article-title":"Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein","volume":"21","author":"Thomas PE","year":"2023","unstructured":"Thomas PE, Vedel-Krogh S, Kamstrup PR, et al.. Lipoprotein(a) is linked to atherothrombosis and aortic valve stenosis independent of C-reactive protein. Eur Heart J. 2023, 21:1449-60. 10.1093\/eurheartj\/ehad055","journal-title":"Eur Heart J"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.018","article-title":"Elevated lipoprotein(a) and risk of atrial fibrillation: an observational and Mendelian randomization study","volume":"26","author":"Mohammadi-Shemirani P","year":"2022","unstructured":"Mohammadi-Shemirani P, Chong M, Narula S, et al.. Elevated lipoprotein(a) and risk of atrial fibrillation: an observational and Mendelian randomization study. J Am Coll Cardiol. 2022, 26:1579-90. 10.1016\/j.jacc.2022.02.018","journal-title":"J Am Coll Cardiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa063","article-title":"Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions","volume":"1","author":"Welsh P","year":"2021","unstructured":"Welsh P, Welsh C, Celis-Morales CA, et al.. Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions. Eur J Prev Cardiol. 2021, 1:1991-2000. 10.1093\/eurjpc\/zwaa063","journal-title":"Eur J Prev Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117217","article-title":"Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: the multi-ethnic study of atherosclerosis","volume":"381","author":"Bhatia HS","year":"2023","unstructured":"Bhatia HS, Rikhi R, Allen TS, et al.. Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2023, 381:117217. 10.1016\/j.atherosclerosis.2023.117217","journal-title":"Atherosclerosis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1031968","article-title":"C-reactive protein for the prediction of cardiovascular risk: ready for prime-time?","volume":"11","author":"Hackam DG","year":"2004","unstructured":"Hackam DG, Shumak SL. C-reactive protein for the prediction of cardiovascular risk: ready for prime-time?. CMAJ Can Med Assoc J. 2004, 11:1563-5. 10.1503\/cmaj.1031968","journal-title":"CMAJ Can Med Assoc J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-021-00546-z","article-title":"Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies","volume":"1","author":"Yang X","year":"2021","unstructured":"Yang X, Zhang D, Zhao Y, et al.. Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies. J Hum Hypertens. 2021, 1:1149-58. 10.1038\/s41371-021-00546-z","journal-title":"J Hum Hypertens"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D203","article-title":"Role of C-reactive protein in cardiovascular disease","volume":"38","author":"Backes J","year":"2004","unstructured":"Backes J, Howard P, Moriarty P. Role of C-reactive protein in cardiovascular disease. Ann Pharmacother. 2004, 38:110-8. 10.1345\/aph.1D203","journal-title":"Ann Pharmacother"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.052","article-title":"C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus","volume":"29","author":"Ridker PM","year":"2007","unstructured":"Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007, 29:2129-38. 10.1016\/j.jacc.2007.02.052","journal-title":"J Am Coll Cardiol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac544.2292","article-title":"Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease","volume":"3","author":"Han E","year":"2022","unstructured":"Han E, Fritzer-Szekeres M, Szekeres T, et al.. Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease. Eur Heart J. 2022, 3:544. 10.1093\/eurheartj\/ehac544.2292","journal-title":"Eur Heart J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.4.389","article-title":"What is C-reactive protein telling us about coronary artery disease?","volume":"25","author":"Levinson SS","year":"2002","unstructured":"Levinson SS, Elin RJ. What is C-reactive protein telling us about coronary artery disease?. Arch Intern Med. 2002, 25:389-92. 10.1001\/archinte.162.4.389","journal-title":"Arch Intern Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"7","author":"Zhang R","year":"2001","unstructured":"Zhang R, Brennan ML, Fu X, et al.. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA. 2001, 7:2136-42. 10.1001\/jama.286.17.2136","journal-title":"JAMA"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800096-0.00001-9","article-title":"Chapter one - myeloperoxidase in cardiovascular disease","author":"Koeth RA","year":"2013","unstructured":"Koeth RA, Haselden V, Tang WHW. Chapter one - myeloperoxidase in cardiovascular disease. Advances in Clinical Chemistry. Makowski GS (ed): Elsevier, Amsterdam, Netherlands; 2013. 62:1-32. 10.1016\/B978-0-12-800096-0.00001-9"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"23","author":"Baldus S","year":"2003","unstructured":"Baldus S, Heeschen C, Meinertz T, et al.. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003, 23:1440-5. 10.1161\/01.CIR.0000090690.67322.51","journal-title":"Circulation"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.01.026","article-title":"Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure","volume":"103","author":"Tang WHW","year":"2009","unstructured":"Tang WHW, Katz R, Brennan ML, et al.. Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure. Am J Cardiol. 2009, 103:1269-74. 10.1016\/j.amjcard.2009.01.026","journal-title":"Am J Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0638","article-title":"Association of serum procalcitonin with cardiovascular prognosis","volume":"75","author":"Sinning CR","year":"2011","unstructured":"Sinning CR, Sinning JM, Schulz A, et al.. Association of serum procalcitonin with cardiovascular prognosis. Circulation. 2011, 75:1184-91. 10.1253\/circj.CJ-10-0638","journal-title":"Circulation"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18357","article-title":"Procalcitonin correlates with cardiovascular risk better than highly sensitive c-reactive protein in patients with type 2 diabetes in sub-Saharan Africa: results from a cross-sectional study","volume":"13","author":"Katte JC","year":"2021","unstructured":"Katte JC, Kengne AP, Tchapmi D, et al.. Procalcitonin correlates with cardiovascular risk better than highly sensitive c-reactive protein in patients with type 2 diabetes in sub-Saharan Africa: results from a cross-sectional study. Cureus. 2021, 13:18357. 10.7759\/cureus.18357","journal-title":"Cureus"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2012.02548.x","article-title":"Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study","volume":"272","author":"Schiopu A","year":"2012","unstructured":"Schiopu A, Hedblad B, Engstr\u00f6m G, et al.. Plasma procalcitonin and the risk of cardiovascular events and death: a prospective population-based study. J Intern Med. 2012, 272:484-91. 10.1111\/j.1365-2796.2012.02548.x","journal-title":"J Intern Med"},{"key":"ref57","article-title":"Components of the complete blood count as risk predictors for coronary heart disease","volume":"40","author":"Madjid M","year":"2013","unstructured":"Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease. Tex Heart Inst J. 2013, 40:17-29.","journal-title":"Tex Heart Inst J"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68319-1","article-title":"Hematocrit, hemoglobin and red blood cells are associated with vascular function and vascular structure in men","volume":"10","author":"Kishimoto S","year":"2020","unstructured":"Kishimoto S, Maruhashi T, Kajikawa M, et al.. Hematocrit, hemoglobin and red blood cells are associated with vascular function and vascular structure in men. Sci Rep. 2020, 10:11467. 10.1038\/s41598-020-68319-1","journal-title":"Sci Rep"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21767","article-title":"Relationship between hematocrit level and cardiovascular risk factors in a community\u2010based population","volume":"21","author":"Jin Y","year":"2014","unstructured":"Jin Y, Zheng D, Duan Z, et al.. Relationship between hematocrit level and cardiovascular risk factors in a community\u2010based population. J Clin Lab Anal. 2014, 21:289-93. 10.1002\/jcla.21767","journal-title":"J Clin Lab Anal"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21661-x","article-title":"Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study","volume":"8","author":"Lassale C","year":"2018","unstructured":"Lassale C, Curtis A, Abete I, van der Schouw YT, Verschuren WMM, Lu Y, Bueno-de-Mesquita HB. Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study. Sci Rep. 2018, 8:3290. 10.1038\/s41598-018-21661-x","journal-title":"Sci Rep"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.16.4.499","article-title":"White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men","volume":"16","author":"Weijenberg MP","year":"1996","unstructured":"Weijenberg MP, Feskens EJM, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol. 1996, 16:4. 10.1161\/01.ATV.16.4.499","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Which white blood cell subtypes predict increased cardiovascular risk?","volume":"17","author":"Horne BD","year":"2005","unstructured":"Horne BD, Anderson JL, John JM, et al.. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol. 2005, 17:1638-43. 10.1016\/j.jacc.2005.02.054","journal-title":"J Am Coll Cardiol"},{"key":"ref63","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"4","author":"Kaptoge S","year":"2012","unstructured":"Kaptoge S, Di Angelantonio E, Pennells L. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012, 4:1310-20.","journal-title":"N Engl J Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1987.03400090067035","article-title":"Fibrinogen and risk of cardiovascular disease. The Framingham Study","volume":"4","author":"Kannel WB","year":"1987","unstructured":"Kannel WB, Wolf PA, Castelli WP, et al.. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA. 1987, 4:1183-6. 10.1001\/jama.1987.03400090067035","journal-title":"JAMA"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.19.6.1368","article-title":"Measuring plasma fibrinogen to predict stroke and myocardial infarction","volume":"19","author":"Maresca G","year":"1999","unstructured":"Maresca G, Di Blasio A, Marchioli R, et al.. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arterioscler Thromb Vasc Biol. 1999, 19:1368-77. 10.1161\/01.ATV.19.6.1368","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.14.1634","article-title":"Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population","volume":"3","author":"Stec JJ","year":"2000","unstructured":"Stec JJ, Silbershatz H, Tofler GH, et al.. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation. 2000, 3:1634-8. 10.1161\/01.CIR.102.14.1634","journal-title":"Circulation"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.584490","article-title":"Creatine kinase activity is associated with blood pressure","volume":"7","author":"Brewster LM","year":"2006","unstructured":"Brewster LM, Mairuhu G, Bindraban NR, et al.. Creatine kinase activity is associated with blood pressure. Circulation. 2006, 7:2034-9. 10.1161\/CIRCULATIONAHA.105.584490","journal-title":"Circulation"},{"key":"ref68","article-title":"Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome","volume":"9","author":"Al-Hadi HA","year":"2009","unstructured":"Al-Hadi HA, Fox KA. Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ Med J. 2009, 9:231-46.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61894-3","article-title":"Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease","volume":"27","author":"Wu YW","year":"2020","unstructured":"Wu YW, Ho SK, Tseng WK, et al.. Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease. Sci Rep. 2020, 27:5638. 10.1038\/s41598-020-61894-3","journal-title":"Sci Rep"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.570762","article-title":"Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men","volume":"28","author":"Zethelius B","year":"2006","unstructured":"Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men. Circulation. 2006, 28:1071-8. 10.1161\/CIRCULATIONAHA.105.570762","journal-title":"Circulation"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0212-3","article-title":"Troponin I in CVD risk prediction","volume":"16","author":"Huynh K","year":"2019","unstructured":"Huynh K. Troponin I in CVD risk prediction. Nat Rev Cardiol. 2019, 16:386. 10.1038\/s41569-019-0212-3","journal-title":"Nat Rev Cardiol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2016.06.002","article-title":"Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations","volume":"27","author":"Everett BM","year":"2017","unstructured":"Everett BM. Cardiac troponin as a novel tool for cardiovascular risk prediction in ambulatory populations. Trends Cardiovasc Med. 2017, 27:41-7. 10.1016\/j.tcm.2016.06.002","journal-title":"Trends Cardiovasc Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"7","author":"Blankenberg S","year":"2016","unstructured":"Blankenberg S, Salomaa V, Makarova N, et al.. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. 2016, 7:2428-37. 10.1093\/eurheartj\/ehw172","journal-title":"Eur Heart J"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100553","article-title":"NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: the getABI-study","volume":"5","author":"Rudolf H","year":"2020","unstructured":"Rudolf H, M\u00fcgge A, Trampisch HJ, et al.. NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: the getABI-study. Int J Cardiol Heart Vasc. 2020, 5:100553. 10.1016\/j.ijcha.2020.100553","journal-title":"Int J Cardiol Heart Vasc"},{"key":"ref75","article-title":"The role of BNP testing in heart failure","volume":"1","author":"Doust J","year":"2006","unstructured":"Doust J, Lehman R, Glasziou P. The role of BNP testing in heart failure. Am Fam Physician. 2006, 1:1893-900.","journal-title":"Am Fam Physician"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.063","article-title":"Association of NT-ProBNP, blood pressure, and cardiovascular events","volume":"9","author":"Hussain A","year":"2021","unstructured":"Hussain A, Sun W, Deswal A, et al.. Association of NT-ProBNP, blood pressure, and cardiovascular events. J Am Coll Cardiol. 2021, 9:559-71. 10.1016\/j.jacc.2020.11.063","journal-title":"J Am Coll Cardiol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.28.3.557","article-title":"Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke","volume":"28","author":"Wannamethee SG","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997, 28:557-63. 10.1161\/01.str.28.3.557","journal-title":"Stroke"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2174\/157016110792006914","article-title":"Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk","volume":"8","author":"Kalaitzidis RG","year":"2010","unstructured":"Kalaitzidis RG, Bakris GL. Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk. Curr Vasc Pharmacol. 2010, 8:604-11. 10.2174\/157016110792006914","journal-title":"Curr Vasc Pharmacol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1140093","article-title":"Serum creatinine levels, traditional cardiovascular risk factors and 10-year cardiovascular risk in Chinese patients with hypertension","volume":"14","author":"Chen X","year":"2023","unstructured":"Chen X, Jin H, Wang D, et al.. Serum creatinine levels, traditional cardiovascular risk factors and 10-year cardiovascular risk in Chinese patients with hypertension. Front Endocrinol. 2023, 14:10.3389\/fendo.2023.1140093","journal-title":"Front Endocrinol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e3181aaee91","article-title":"Vitamin D deficiency and risk for cardiovascular disease","volume":"338","author":"Judd SE","year":"2009","unstructured":"Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci. 2009, 338:40-4. 10.1097\/MAJ.0b013e3181aaee91","journal-title":"Am J Med Sci"},{"key":"ref81","article-title":"Role of Vitamin D deficiency in heart disease","volume":"41","author":"Saljoughian M","year":"2016","unstructured":"Saljoughian M. Role of Vitamin D deficiency in heart disease. US Pharm. 2016, 41:43-5.","journal-title":"US Pharm"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"29","author":"Wang TJ","year":"2008","unstructured":"Wang TJ, Pencina MJ, Booth SL, et al.. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008, 29:503-11. 10.1161\/CIRCULATIONAHA.107.706127","journal-title":"Circulation"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin d in the United States: data from the third national health and nutrition examination survey","volume":"11","author":"Martins D","year":"2007","unstructured":"Martins D, Wolf M, Pan D, et al.. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin d in the United States: data from the third national health and nutrition examination survey. Arch Intern Med. 2007, 11:1159-65. 10.1001\/archinte.167.11.1159","journal-title":"Arch Intern Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.2174\/1570161119666210812152802","article-title":"Pathogenic mechanisms of trimethylamine n-oxide-induced atherosclerosis and cardiomyopathy","volume":"20","author":"Zheng Y","year":"2022","unstructured":"Zheng Y, He JQ. Pathogenic mechanisms of trimethylamine n-oxide-induced atherosclerosis and cardiomyopathy. Curr Vasc Pharmacol. 2022, 20:29-36. 10.2174\/1570161119666210812152802","journal-title":"Curr Vasc Pharmacol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.01.020","article-title":"Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study","volume":"236","author":"Tang WHW","year":"2021","unstructured":"Tang WHW, Li XS, Wu Y, et al.. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk Prospective Population Study. Am Heart J. 2021, 236:80. 10.1016\/j.ahj.2021.01.020","journal-title":"Am Heart J"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.118.311023","article-title":"Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes","volume":"38","author":"Haghikia A","year":"2018","unstructured":"Haghikia A, Li XS, Liman TG, et al.. Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler Thromb Vasc Biol. 2018, 38:2225-35. 10.1161\/ATVBAHA.118.311023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref87","article-title":"Normal and abnormal complete blood count with differential","author":"El Brihi J","year":"2024","unstructured":"El Brihi J, Pathak S. Normal and abnormal complete blood count with differential. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref88","unstructured":"Serum creatinine test for kidney disease. (2024). https.\/\/www.kidneyfund.org\/all-about-kidneys\/tests\/serum-creatinine-test."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276775-a-narrative-review-of-the-role-of-blood-biomarkers-in-the-risk-prediction-of-cardiovascular-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:27:26Z","timestamp":1733052446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276775-a-narrative-review-of-the-role-of-blood-biomarkers-in-the-risk-prediction-of-cardiovascular-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":88,"URL":"https:\/\/doi.org\/10.7759\/cureus.74899","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}